Amblyotech Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

Amblyotech General Information

Description

Developer of medical modalities platform designed to offer novel medical treatments for treating amblyopia and other ocular disorders. The company's platform uses active gaming and passive video technology with 3-D glasses, training the eyes to work together to view an image in full, enabling clients to access revolutionary treatment for ocular disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 77 East Missouri Avenue
  • Unit 67
  • Phoenix, AZ 85012
  • United States
+1 (480)
Primary Industry
Other Healthcare Technology Systems
Other Industries
Entertainment Software
Acquirer
Vertical(s)
SaaS, Gaming, TMT, HealthTech
Corporate Office
  • 77 East Missouri Avenue
  • Unit 67
  • Phoenix, AZ 85012
  • United States
+1 (480)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amblyotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 01-Apr-2020 Completed Generating Revenue
3. Later Stage VC 24-Jan-2020 Completed Generating Revenue
2. Later Stage VC 24-Jul-2019 $150K Completed Generating Revenue
1. Accelerator/Incubator 01-May-2016 $150K $150K Completed Generating Revenue
To view Amblyotech’s complete valuation and funding history, request access »

Amblyotech Patents

Amblyotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230149249-A1 Method of improving stereoacuity using an interval-based protocol Pending 07-Feb-2020
EP-4099972-A1 Method of improving stereoacuity using an interval-based protocol Inactive 07-Feb-2020
AU-2018373510-A1 Method and apparatus for treating diplopia and convergence insufficiency disorder Inactive 24-Nov-2017
US-20190159956-A1 Method and apparatus for treating diplopia and convergence insufficiency disorder Inactive 24-Nov-2017
US-20200306124-A1 Method and apparatus for treating diplopia and convergence insufficiency disorder Inactive 24-Nov-2017 A61B3/08
To view Amblyotech’s complete patent history, request access »

Amblyotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amblyotech Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jumpstart Foundry Venture Capital Minority
Jumpstart Health Investors VC-Backed Company Minority
Novartis Venture Fund Corporate Venture Capital Minority
To view Amblyotech’s complete investors history, request access »

Amblyotech FAQs

  • When was Amblyotech founded?

    Amblyotech was founded in 2013.

  • Where is Amblyotech headquartered?

    Amblyotech is headquartered in Phoenix, AZ.

  • What is the size of Amblyotech?

    Amblyotech has 3 total employees.

  • What industry is Amblyotech in?

    Amblyotech’s primary industry is Other Healthcare Technology Systems.

  • Is Amblyotech a private or public company?

    Amblyotech is a Private company.

  • What is Amblyotech’s current revenue?

    The current revenue for Amblyotech is .

  • How much funding has Amblyotech raised over time?

    Amblyotech has raised $885K.

  • Who are Amblyotech’s investors?

    Jumpstart Foundry, Jumpstart Health Investors, and Novartis Venture Fund have invested in Amblyotech.

  • When was Amblyotech acquired?

    Amblyotech was acquired on 01-Apr-2020.

  • Who acquired Amblyotech?

    Amblyotech was acquired by Novartis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »